Scientists enlist engineered protein to battle the MERS virus

May 19, 2017
MERS particles are attached to the surface of an infected human cell. Credit: NIAID

In June 2012, a 60 year-old man with flu-like symptoms walked into a private hospital in Jeddah, Saudi Arabia. Two weeks later, he died from multiple organ failure, becoming the first victim of a mysterious virus that came to be known as Middle East Respiratory Syndrome or MERS.

The World Health Organization (WHO) has identified MERS as an urgent threat with no vaccine or treatment in sight. This could change thanks to a new anti-viral tool, developed by University of Toronto researchers.

Writing in the journal PLoS Pathogens, the team led by Professor Sachdev Sidhu, of the Donnelly Centre for Cellular and Biomolecular Research and Department of Molecular Genetics, describe how they turned , a staple in every cell, into a drug capable of thwarting MERS in cultured . Because the technology can be applied to a wide range of pathogens, it could become a game-changer in anti-viral therapeutics with implications for human health and the farming industry.

"Vaccines are important for prevention, but there is a great need for anti-viral medicines to treat people who have become infected," says Dr. Wei Zhang, a postdoctoral research fellow in Sidhu's lab who did most of the work on the study.

MERS is similar to SARS, the virus that killed almost 800 people in a 2002 global epidemic. Both kill upwards of a third of people infected and, like many viruses, emerged from animals—bats and camels in the case of MERS—after mutating into a form capable of infecting human cells. Although MERS has so far been detected in 27 countries since the first case emerged in 2012, the outbreak has largely been contained within Saudi Arabia, according to the WHO.

Like many viruses, MERS works by hijacking the ubiquitin system in human cells composed of hundreds of proteins that rely on ubiquitin to keep the cells alive and well. Upon infection, viral enzymes alter ubiquitin pathways in a way that allows the virus to evade the immune defense while multiplying and destroying the host tissue as it spreads in the body.

"Viruses have evolved proteins that allow them to hijack host proteins. We can now devise strategies to prevent this from happening," says Zhang.

Engineered ubiquitins (blue and red squiggles on the left) are similar to normal ubiquitin (orange squiggle on the right) but they can paralyze the V-shaped MERS enzyme by binding to it more tightly. Credit: Dr. Wei Zhang

Zhang and colleagues engineered the human ubiquitin protein into a new form that paralyses a key MERS enzyme, stopping the virus from replicating. These synthetic ubiquitin variants act quickly, completely eliminating MERS from cells in a dish within 24 hours.

The researchers also created UbVs that blocks the Crimean-Congo virus, the cause of a haemorrhagic fever that kills about 40 per cent of those infected.

And they're designed to only target only the virus—hopefully minimizing side effects in any future drug.

But before these engineered proteins can be developed into medicine, researchers first must find a way to deliver them into the right part of the body. For this, Zhang and Sidhu are working with Dr. Roman Melnyk, a biochemist in The Hospital for Sick Children and a world expert in protein delivery.

The team is also investigating the possibility of finding drugs that work in a similar manner but can already cross the cell membrane.

It is likely that the proteins will be tested first in plants and animals where regulatory approvals are less strict than they are for human drugs. "We are also working on an engineered ubiquitin that targets a corn responsible for destroying large swaths of corn fields in North America, with colleagues in Manitoba," says Zhang.

In the meantime, Zhang will continue to improve delivery of his designer proteins to human that target not only MERS but also other viruses. He hopes others will follow suit.

"With our tool, we can quickly generate anti-viral medicine and we hope that our method will inspire other researchers to try it out against diverse pathogens," says Zhang.

Explore further: Researchers combine MERS and rabies viruses to create innovative 2-for-1 vaccine

More information: Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants, PLoS Pathogens (2017). journals.plos.org/plospathogen … journal.ppat.1006372

Related Stories

Researchers combine MERS and rabies viruses to create innovative 2-for-1 vaccine

December 7, 2016
In a new study, researchers have modified a rabies virus, so that it has a protein from the MERS virus; this altered virus works as a 2-for-1 vaccine that protects mice against both Middle East Respiratory Syndrome (MERS) ...

Scientists find mystery virus in camels in Qatar

November 29, 2013
Health officials say they have found a mysterious respiratory virus in a herd of camels in Qatar linked to two human cases of the disease.

MERS virus kills man in UAE

January 27, 2016
The MERS coronavirus has killed a man in the United Arab Emirates, the Abu Dhabi health authority said on Tuesday.

Saudi man dies of MERS virus: ministry

July 28, 2013
A Saudi man has died of the coronavirus MERS and another has contracted the virus, the health ministry said on Saturday, bringing the kingdom's deaths from the virus to 39.

Jordanian dies of MERS virus

May 6, 2014
A man has died in Jordan after being infected with the MERS virus, a media report said Tuesday, in the kingdom's second fatality from the disease this year and fourth since 2012.

MERS infections more widespread, less deadly than thought, study finds

April 16, 2015
The viral respiratory disease MERS, first identified in 2012 in Saudi Arabia, is apparently more widespread but less deadly than originally thought, according to a German study.

Recommended for you

Zika virus stifles pregnant women's weakened immune system to harm baby, study finds

August 21, 2017
The Zika virus, linked to congenital birth defects and miscarriages, suppresses a pregnant woman's immune system, enabling the virus to spread and increasing the chances an unborn baby will be harmed, a Keck School of Medicine ...

Fatty liver can cause damage to other organs via crosstalk

August 21, 2017
Nonalcoholic fatty liver disease is increasingly common. Approximately every third adult in industrialized countries has a morbidly fatty liver. This not only increases the risk of chronic liver diseases such as liver cirrhosis ...

Novel approach to track HIV infection

August 18, 2017
Northwestern Medicine scientists have developed a novel method of tracking HIV infection, allowing the behavior of individual virions—infectious particles—to be connected to infectivity.

Faulty gene linked to obesity in adults

August 18, 2017
Groundbreaking new research linking obesity and metabolic dysfunction to a problem in the energy generators in cells has been published by researchers from the Harry Perkins Institute of Medical Research and The University ...

Two lung diseases killed 3.6 million in 2015: study

August 17, 2017
The two most common chronic lung diseases claimed 3.6 million lives worldwide in 2015, according to a tally published Thursday in The Lancet Respiratory Medicine.

New test differentiates between Lyme disease, similar illness

August 16, 2017
Lyme disease is the most commonly reported vector-borne illness in the United States. But it can be confused with similar conditions, including Southern Tick-Associated Rash Illness. A team of researchers led by Colorado ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.